MIRA Pharmaceuticals Statistics
Total Valuation
MIRA has a market cap or net worth of $10.18 million. The enterprise value is $6.65 million.
| Market Cap | 10.18M |
| Enterprise Value | 6.65M |
Important Dates
The next estimated earnings date is Friday, September 13, 2024, after market close.
| Earnings Date | Sep 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MIRA has 14.78 million shares outstanding. The number of shares has increased by 11.03% in one year.
| Shares Outstanding | 14.78M |
| Shares Change (YoY) | +11.03% |
| Shares Change (QoQ) | +6.15% |
| Owned by Insiders (%) | 29.11% |
| Owned by Institutions (%) | 4.27% |
| Float | 9.07M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 3.23 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.70, with a Debt / Equity ratio of 0.00.
| Current Ratio | 5.70 |
| Quick Ratio | 5.56 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2.63 |
Financial Efficiency
Return on equity (ROE) is -293.50% and return on invested capital (ROIC) is -283.56%.
| Return on Equity (ROE) | -293.50% |
| Return on Assets (ROA) | -229.00% |
| Return on Capital (ROIC) | -283.56% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$4.12M |
| Employee Count | 3 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 0.73 |
| 200-Day Moving Average | 1.41 |
| Relative Strength Index (RSI) | 49.11 |
| Average Volume (20 Days) | 1,679,382 |
Short Selling Information
The latest short interest is 15,639, so 0.11% of the outstanding shares have been sold short.
| Short Interest | 15,639 |
| Short Previous Month | 64,884 |
| Short % of Shares Out | 0.11% |
| Short % of Float | 0.17% |
| Short Ratio (days to cover) | 0.43 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -8.95M |
| Pretax Income | -12.36M |
| Net Income | -12.36M |
| EBITDA | -8.95M |
| EBIT | -8.95M |
| Earnings Per Share (EPS) | -$0.67 |
Balance Sheet
The company has $3.53 million in cash and $1,273 in debt, giving a net cash position of $3.53 million or $0.24 per share.
| Cash & Cash Equivalents | 3.53M |
| Total Debt | 1,273 |
| Net Cash | 3.53M |
| Net Cash Per Share | $0.24 |
| Equity (Book Value) | 3.16M |
| Book Value Per Share | 0.21 |
| Working Capital | 3.06M |
Cash Flow
| Operating Cash Flow | -4.51M |
| Capital Expenditures | n/a |
| Free Cash Flow | -4.51M |
| FCF Per Share | -$0.23 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIRA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.03% |
| Shareholder Yield | -11.03% |
| Earnings Yield | -121.39% |
| FCF Yield | -44.26% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |